Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Ma... von Horwitz, Steven M., Foran, James M., Maris, Michael, Sawas, Ahmed, Okada, Craig, Feldman, Tatyana A., Minden, Mark D., Sokol, Lubomir, Mei, Matthew, Flinn, Ian W., Villa, Diego, Percival, Mary-Elizabeth M., Jagadeesh, Deepa, Savage, Kerry J., Akilov, Oleg E., Diefenbach, Catherine, Kim, Youn H., Lin, Gloria H.Y., Catalano, Tina, Petrova, Penka S., Uger, Bob, Molloy, Naomi, Large, Kathleen, Shou, Yaping, Ansell, Stephen M.

Volltext

Intralesional Injection of the CD47-blocking immune checkpoint inhibitor TTI-621 (SIRPaFc) induces antitumor activity in patients with relapsed/refractory mycosis fungoides and Séz... von Querfeld, Christiane, Thompson, John A., Taylor, Matthew, Pillai, Raju, Johnson, Lisa DS, Catalano, Tina, Petrova, Penka S., Uger, Bob A., Irwin, Meghan, Thompson, Theresa, Sievers, Eric L., Akilov, Oleg

Volltext

TARGETED IMMUNOGENS von GUO, YONG, CHENG, SU, UGER, BOB, SALHA, DANIELLE, BARBER, BRIAN, MORSE, BUZZY

Volltext bestellen

TARGETED IMMUNOGENS von GUO, YONG, CHENG, SU, UGER, BOB, SALHA, DANIELLE, BARBER, BRIAN, MORSE, BUZZY

Volltext bestellen

TARGETED IMMUNOGENS von GUO, YONG, CHENG, SU, SALHA, DANIELLE, UGER, BOB, BARBER, BRIAN, MORSE, BUZZY

Volltext bestellen

TARGETED IMMUNOGENS von GUO, YONG, CHENG, SU, UGER, BOB, SALHA, DANIELLE, BARBER, BRIAN, MORSE, BUZZY

Volltext bestellen